Yonsei Medical Journal · 2016 · 20 citations · 27 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor PathologyCancer Molecular PathologyMalignant NeoplasmsMolecular Classification Of TumorsOvarian CancerOvarian NeoplasiaOvarian PathologyClear Cell NeoplasmsImmunohistochemical BiomarkersImmunohistochemical MarkersImmunohistochemical StainingMalignant Ovarian NeoplasmsOvarian Tumor GradingPrimary Tumor CharacterizationPrimary Tumor Classification
PURPOSE: Loss of AT-rich DNA-interacting domain 1A (ARID1A) has been identified as a driving mutation of ovarian clear cell carcinoma (O-CCC), a triple-negative ovarian cancer that is intermediary between serous and endometrioid subtypes, in regards to molecular and clinical behaviors. However, about half of O-CCCs still express BAF250a, the protein encoded by ARID1A. Herein, we aimed to identify signatures of ARID1A-positive O-CCC in comparison with its ARID1A-negative counterpart. MATERIALS AND METHODS: Seventy cases of O-CCC were included in this study. Histologic grades and patterns of primary tumor, molecular marker immunohistochemistry profiles, and clinical outcomes were analyzed. RESULTS: Forty-eight (69%) O-CCCs did not express BAF250a, which were designated as "ARID1A-negative." The other 22 (31%) O-CCCs were designated as "ARID1A-positive." ARID1A-positive tumors were more likely to be histologically of high grades (41% vs. 10%, p=0.003), ERβ-positive (45% vs. 17%, p=0.011), and less likely to be HNF1β-positive (77% vs. 96%, p=0.016) and E-cadherin-positive (59% vs. 83%, p=0.028) than ARID1A-negative tumors. Patient age, parity, tumor stage were not significantly different in between the two groups. Cancer-specific survival was not significantly different either. CONCLUSION: We classified O-CCCs according to ARID1A expression status. ARID1A-positive O-CCCs exhibited distinct immunohistochemical features from ARID1A-negative tumors, suggesting a different underlying molecular event during carcinogenesis.
27
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand, Sohrab P. Shah, Osama M. Al‐Agha et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text
Frequent Mutations of Chromatin Remodeling Gene <i>ARID1A</i> in Ovarian Clear Cell Carcinoma
Siân Jones, Tian‐Li Wang, Ie‐Ming Shih et al. · Science · 2010 · 1.2K citations
Expression Profiling in Ovarian Clear Cell Carcinoma
Akira Tsuchiya, Michiie Sakamoto, Jun Yasuda et al. · American Journal Of Pathology · 2003 · 313 citations · Full text